ErbB2 Positive Metastatic Breast Cancer

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Chang-Fang Chiu, China Medical University Hospital
ClinicalTrials.gov Identifier:
NCT01658358
First received: August 1, 2012
Last updated: February 26, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2014
  Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)